Nucleic Acid Pathogen Testing - Cigna
Medical Coverage Policy Effective Date ........................................ ..... 9/15/2021. Next Review 1/15/2022. Coverage Policy Number .................................. 0530. Nucleic acid Pathogen Testing Table of Contents Related Coverage Resources Overview ........................................ ...................... 1 Preventive Care Services Coverage General Background ........................................ ....3. Medicare Coverage Determinations ....................8. Coding/Billing Information ....................................9. References ........................................ ................36. INSTRUCTIONS FOR USE. The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients.
on easily obtainable specimens such as vaginal swabs (either clinician- or patient-collected) or urine. Chlamydia can be diagnosed by testing first-catch urine in both males and females or collecting swab specimens from the endocervix or vagina in females or the urethra in males. Rectal and oropharyngeal chlamydial infection in
Download Nucleic Acid Pathogen Testing - Cigna
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: